全膝关节置换术后假体周围关节感染行清创、抗生素及假体保留治疗成功后的结局
单中心2008至2020年191例全膝关节置换术后急性假体周围关节感染行清创、抗生素及假体保留(DAIR)治疗,60例获得患者报告结局评分。成功DAIR后膝关节与心理健康结局与无并发症全膝关节置换相似,生理健康评分较低;5年无因感染再手术生存率为79%。
要点
- 成功DAIR后KOOS-JR与PROMIS心理健康评分与无并发症全膝关节置换无显著差异。
- DAIR组PROMIS生理健康评分低于对照组(P = .048)。
- DAIR治疗急性假体周围关节感染5年无因感染再手术生存率为79%。
核心结论
- 成功DAIR术后膝关节与心理健康结局与无并发症全膝关节置换相似,DAIR治疗急性假体周围关节感染5年成功率为79%。
研究设计与样本
- 单中心2008至2020年识别191例DAIR病例,其中60例获得患者报告结局评分,并与按年龄、体重指数和性别匹配的无并发症全膝关节置换队列比较。
主要发现
- DAIR组平均KOOS-JR为57.2 ± 19.7,PROMIS生理健康为41.6 ± 7.1,PROMIS心理健康为46.6 ± 8.7。
- 对照组平均KOOS-JR为65.8 ± 21.0,PROMIS生理健康为44.6 ± 8.4,PROMIS心理健康为49.2 ± 9.2。
- KOOS-JR(P = .83)与PROMIS心理健康(P = .11)无差异,DAIR组PROMIS生理健康低于对照组(P = .048)。
- 全部191例中位随访5.9年(范围0.5至13.1年),无因感染再手术生存率1年为84%、2年为82%、5年为79%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Controversy surrounds debridement, antibiotic and implant retention (DAIR) for treatment of acute periprosthetic joint infection (PJI). Data regarding DAIR's rate of infection resolution is variable with little investigation of functional outcomes. METHODS: We identified 191 DAIR cases at a single institution from 2008 to 2020. Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS-JR) and Patient Reported Outcome Measurement Information System-10 (PROMIS) scores were collected. Patient Reported Outcome Scores were obtained from 60 cases. Median follow-up (IQR) was 4.5 (2.1 to 7.6) versus 3.0 (1.2 to 5.3) years for the control group. Mean scores were compared to a cohort of uncomplicated total knee arthroplasties matched by age, body mass index, and sex using generalized linear models adjusted for follow-up duration. Kaplan-Meier survivorship curves for PJI were constructed. RESULTS: Mean Patient Reported Outcome Scores for the DAIR cohort were 57.2 ± 19.7 for KOOS-JR, 41.6 ± 7.1 for PROMIS physical health (PH), and 46.6 ± 8.7 for PROMIS mental health (MH). Mean control group values were 65.8 ± 21.0 for KOOS-JR, 44.6 ± 8.4 for PROMIS PH, and 49.2 ± 9.2 for PROMIS MH. No difference was observed in KOOS-JR (P = .83) or PROMIS MH (P = .11). PROMIS PH was lower in the DAIR cohort compared to the control group (P = .048). Median follow-up (years) for all 191 cases was 5.9 (range, 0.5 to 13.1). Survivorship (years) without subsequent operation for infection was 84% at 1, 82% at 2, and 79% at 5. CONCLUSION: Knee and MH outcomes in successful DAIR procedures were similar to uncomplicated total knee arthroplasty. DAIR's success rate was 79% in treating acute PJI at 5 years. LEVEL OF EVIDENCE: Level III.
引用
- Van Engen MG, Carender CN, Glass NA, et al. Outcomes After Successful Debridement, Antibiotic, and Implant Retention Therapy for Periprosthetic Joint Infection in Total Knee Arthroplasty. J Arthroplasty. 2023. PMID: 37572722. doi:10.1016/j.arth.2023.08.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。